Fluxome
NEWS
ProductsCompany
NewsInvestor Relations
BackgroundContact


PRESS RELEASE: Fluxome to strengthen its technology platform through extensive European modeling tool project
(01.05.2012)

 

The BioPreDyn Project aims at the development of novel computational tools, methods, and algorithms, and will integrate these into a user-friendly software platform. The project has a EUR 2.9 million budget and will among other things enable Fluxome to further improve the production processes for nutraceutical ingredients.

__________________________________________________________________________________________

 

Fluxome takes up the role as industrial partner in an ambitious European project aiming at the development of novel computational tools, methods, and algorithms, and the integration of these into a user-friendly software platform for research institutions as well as companies such as Fluxome operating in the industrial biotech sector. In the long run, these new modeling tools will allow the design and optimization of biotechnological production processes in a reliable, predictive and quantitative way.

 

Fluxome will benefit significantly from this project as it will enable the further improvement of production processes for nutraceutical ingredients. The final outcome will be an even stronger technology platform, which will improve Fluxome's ability to screen product ideas as well as develop and produce high quality nutraceutical ingredients for the dietary supplements, food, beverage and cosmetics industries.

 

 

"We are very excited to be part of this project as it will allow us to work with the leading researchers in the area of computational tools, speed up our research and development activities and provide useful methods to support our cutting edge technology platform", adds Marketing Director at Fluxome Mads Bjørnhof.

 

"I believe this is something that can support and shorten the time it takes to convert a promising idea into an attractive commercial product. In that sense, I think this project can expand the market opportunities and widen the range of product candidates Fluxome can pursue in the future", states Director of R&D at Fluxome Jean-Marie Mouillon.

 

New Bioinformatics Methods and Tools for Data-Driven, Predictive Dynamic Modelling in Biotechnological Applications (BioPreDyn project) will include 8 academic labs and 3 industrial partners from countries all across Europe. It is a three-year project with a budget of €2.9 million from the 7th Framework Program of the European Commission.

 

The project is coordinated by the Centre for Genomic Regulation (CRG) in Barcelona, which will be responsible for developing innovative solutions by embracing collective expertise and synergies between interdisciplinary areas such as database development, scientific visualization methods, statistics, machine learning, mathematical modeling and biotechnological engineering.

 

Julio R. Banga (CSIC, Vigo) - one of the scientific coordinators of the project - emphasizes that "BioPreDyn presents a holistic approach to model building in bioinformatics and systems biology targeting both fundamental theory and real-world applications". His colleague and co-coordinator Johannes Jaeger, points out that the project is indispensable as it "aims at creating an integrated suite of robust and solid methods to empower data-driven modeling for the systems biology and biotechnology of the future, shortening the lag time from ideas to the market".

 

For more information please contact Mr. Jean Marie Mouillon, Director of Research and Development, jmm@fluxome.com.

 

Download Press Release

 





01.05.12
PRESS RELEASE: Fluxome to strengthen its technology platform through extensive European modeling tool project
Read moreread more
18.11.11
New Clinical study about Resveratrol shows positive effects in humans.
Read moreread more
11.11.11
Growing interest in Resveratrol's health drives focus on research.
Read moreread more
14.10.11
This years 15 anniversary SupplySide West show held in Las Vegas was a great success. With more than 1300 exhibitioners Fluxome was one of many who were at place in order to tell the latest news on Resveratrol, PUFA and Beta Glucan. Over 9700 people were visiting during the two day conference.
Read moreread more
10.10.11
Fluxome at SupplySide West 2011: Come visit us at booth # 24111.
Read moreread more
06.10.11
Please visit our Careers page and have a look at the exiting new positions Fluxome are currently offering.
Read moreread more
01.10.11
NEW VACANCIES: Fluxome has the following vacant positions: PROJECT MANAGER, FERMENTATION SPECIALIST, and DOWNSTREAM PROCESSING SPECIALIST
Read moreread more
22.09.11
Fluxome is proud to announce that Dr. Richard Baerends, Ph D. Microbiology will start as Metabolig Engineering Scientist at Fluxome in Stenlose. Richard will join Fluxome September 26. 2011
Read moreread more
02.09.11
TWO NEW VACANCIES: Fluxome continues to expand and are therefore looking for two new scientists - one Cell Biologist Scientist and one Metabolic Engineering Scientist. Please read the job adds under CAREERS
Read moreread more
10.08.11
Fluxome has hiered Ina Dosen as new Analytical Research Scientist per August 1st 2011
Read moreread more
10.08.11
Fluxome is proud to announce that Dr. Jean-Marie Mouillon has been promoted to Director of Research and Development. Jean-Marie Mouillon has been with Fluxome since 2006 and hold strong expertise within metabolic engineering and strain construction.
Read moreread more
09.08.11
NEW VACCANCY: Fluxome is looking for a full time laboratory Assistant. Start date September 1. 2011.
Read moreread more
05.07.11
Again this year Fluxome will be at the SupplySideWest - celebrating its 15th anniversary this year.
Read moreread more
04.07.11
Fluxome will be represented at The Food & Health Partnering Forum Norway September 13. and 14. 2011.
Read moreread more
07.06.11
NEW VACANCY: Fluxome søger laborant/tekniker med flair for bioproces & fermentering. Til vores FRANDS (Fermentering, Analyse og Downstream) team, søger vi en struktureret & fleksibel tekniker til vores laboratoriefermenteringer.
Read moreread more
01.06.11
NEW VACANCY: As Fluxome is strengthening its R&D organization we are looking for a full time Analytical Research Scientist that can maintain and drive the development of our Analytical platform.
Read moreread more
24.05.11
NEW VACANCY: Competent student needed in marketing and product management function! As Fluxome increases its sales and marketing efforts we are looking for a student to join our team as Marketing Assistant in order to further strengthen our ability to market our unique products.
Read moreread more
16.05.11
"Rise to the Challenge, Seize the Opportunity" is the headline of the 13th Annual C21 BioVentures. This refers to the new challenges and opportunities for pharmaceutical partners and investors as well as for biotech companies. With podium presentations, leadership sessions and two-full days of face-to-face partnering meetings C21 is an opportunity you shouldn't miss.
Read moreread more
09.05.11
PRESS RELEASE: Fluxome® Resveratrol has obtained self affirmed GRAS and it has thus been confirmed to be safe to use as a food ingredient. The self affirmed GRAS status enables further use of natural resveratrol in food and beverage applications.
Read moreread more
08.05.11
HAPPENING RIGHT NOW: Chief Operating Officer at Fluxome Dr. Jochen Förster will present the latest achievements on Fluxome Resveratrol May 9th 2011 at 10:45:00 AM at the The World Congress on Industrial Biotechnology & Bioprocessing in Toronto, Canada.
Read moreread more
02.05.11
NEW VACANCY: Fluxome is seeking two Bachelor students in laboratory technology. We offer a position both in our fermentation and analysis team and in our Metabolig Engineering team.
Read moreread more
02.05.11
HAPPENING RIGHT NOW: Fluxome is exhibiting at Supply Side East in Secaucus, NJ. Please feel free to stop by our booth, 1434 at Meadowlands Exposition Center, Secaucus, NJ.
Read moreread more
12.04.11
The World Congress on Industrial Biotechnology & Bioprocessing is taking place 8.5. – 11.5. in Toronto, Canada. Here Chief Operating Officer Dr. Jochen Förster will present latest achievements on Fluxome Resveratrol.
Read moreread more
04.04.11
PRESS RELEASE: Fluxome® Resveratrol has obtained self affirmed GRAS and it has thus been confirmed to be safe to use as a food ingredient. The self affirmed GRAS status enables further use of natural resveratrol in food and beverage applications.
Read moreread more
29.03.11
Chief Operating Officer Dr. Jochen Förster will present Fluxome Business at Nutrition Capital Network Spring 2011 Investor Meeting from April 11– 12 2011 in New York USA.
Read moreread more
16.03.11
Fluxome will participate in the worlds largest climate campaign, Earth Hour which this year is taking place at Saturday March 26th 2011 at 8:30 PM (local time).
Read moreread more
16.02.11
PRESS RELEASE: LIRMOI Project puts Denmark in the Forefront of Global Resveratrol Research
Read moreread more
09.02.11
NEW EMPLOYEE: Richard Bernard, Director of Sales, Eastern Region
Read moreread more
21.01.11
NEWS RELEASE: Does your supplement deliver the resveratrol you expect?
Read moreread more
13.01.11
PRESS RELEASE: USD 3.4 M (DKK 19 M) For Resveratrol Research in Denmark
Read moreread more
13.01.11
TWO NEW EMPLOYEES: Camilla O. Samuelsen adn Lasse Pedersen
Read moreread more
20.12.10
Vacancy per February 1st 2011 as Laboratory trainee with Fluxome A/S We offer a position with great possibility for archiving thorough practical knowledge within chemical analytical methods and quality assurance. Deadline January 10th 2011
Read moreread more
05.11.10
NEWS RELEASE: Fluxome® Resveratrol on the air! Fluxome was recently interviewed on the Danielle Lin Radio Show. Download and listen!
Read moreread more
08.10.10
FLUXOME AT SUPPLYSIDE WEST: Expert gives speech about novel production methods of beta glucans
Read moreread more
08.09.10
PRESS RELEASE: "An investment in Fluxome is an investment in green and clean technology"
Read moreread more
18.08.10
New document available: Fluxome® Beta Glucan Triple Helix Efficacy
Read moreread more
21.07.10
New document available: Beta Glucan Efficacy
Read moreread more
05.07.10
The Ups and Downs of Resveratrol
Read moreread more
30.06.10
Fluxome® Beta Glucan Efficacy
Read moreread more
07.06.10
Three new documents concerning the health effects of resveratrol are now available for download!
Read moreread more
17.05.10
Fluxome® Resveratrol Valued as Safe According to Independent Expert Panel
Read moreread more
10.05.10
PRESS RELEASE: Fluxome Inc is growing and has moved its headquarters to Easton, PA. The US based company Fluxome Inc has added a new member of staff: Mrs. Nicole Chilmonik.
Read moreread more
19.03.10
Announcement at Supply Side East 2010
Read moreread more
15.03.10
Fluxome and GlycaNova join forces to bring a promising beta glucan product to the US dietary supplement market
Read moreread more
06.02.10
New Product: Fluxome® Beta Glucan for Immune Health
Read moreread more
07.01.10
Fluxome appoints new downstream specialist
Read moreread more
29.10.09
Fluxome opens sales office in USA and appoints CEO
Read moreread more
23.10.09
Fluxome at Supply Side East 2009 - Come visit our booth
Read moreread more
06.10.09
Resveratrol promoted by the media's opinion leaders
Read moreread more
24.07.09
Fluxome moves to new global headquarters
Read moreread more
23.07.08
Fluxome Sciences Expands Capital by DKK 100 mio /EUR 13 mio
Read moreread more
18.06.08
Fluxome and CP Kelco U.S., Inc. Join Forces in Resveratrol
Read moreread more